ORIGINAL RESEARCH
Published on 29 May 2024
Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome
doi 10.3389/fimmu.2024.1401683
- 2,554 views
- 2 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II
Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II
21k
Total downloads
64k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 07 Dec 2023
CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer
doi 10.3389/fimmu.2023.1302307
- 3,489 views
- 2 citations
REVIEW
Published on 28 Nov 2023
Advancing CAR-based immunotherapies in solid tumors: CAR- macrophages and neutrophils
doi 10.3389/fimmu.2023.1291619
- 4,053 views
- 10 citations
ORIGINAL RESEARCH
Published on 27 Oct 2023
Mediport use as an acceptable standard for CAR T cell infusion
doi 10.3389/fimmu.2023.1239132
- 2,635 views
ORIGINAL RESEARCH
Published on 18 Oct 2023
NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells
doi 10.3389/fimmu.2023.1187665
- 3,036 views
- 3 citations
ORIGINAL RESEARCH
Published on 17 Oct 2023
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
doi 10.3389/fimmu.2023.1219165
- 2,152 views
REVIEW
Published on 15 Aug 2023
Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML
doi 10.3389/fimmu.2023.1202950
- 4,690 views
- 5 citations
CASE REPORT
Published on 29 Nov 2022
Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase
doi 10.3389/fimmu.2022.1012981
- 3,260 views
- 6 citations
REVIEW
Published on 22 Nov 2022
CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil
doi 10.3389/fimmu.2022.1018786
- 13,112 views
- 37 citations
ORIGINAL RESEARCH
Published on 06 Oct 2022
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
doi 10.3389/fimmu.2022.1011858
- 4,638 views
- 9 citations
ORIGINAL RESEARCH
Published on 28 Sep 2022
Transcriptional states of CAR-T infusion relate to neurotoxicity – lessons from high-resolution single-cell SOM expression portraying
doi 10.3389/fimmu.2022.994885
- 2,624 views
- 5 citations
ORIGINAL RESEARCH
Published on 23 Aug 2022
Impact of glucocorticoids on short-term and long-term outcomes in patients with relapsed/refractory multiple myeloma treated with CAR-T therapy
doi 10.3389/fimmu.2022.943004
- 2,051 views
- 10 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 64kTopic views
- 42kArticle views
- 21kArticle downloads